Answers are grounded in this paper and cite their sources.
Infliximab seems to be a very effective therapy for osteoarticular complaints of SAPHO syndrome. Cutaneous involvement responded less favourably, palmoplantaris pustulosis relapse being a possible complication.
No takes yet. Share an insight, caveat, or question.
Massara et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: